BioNTech SE
Price & Volume
Stats
See moreOpen | $96.95 |
Previous Close | $96.70 |
Day Range | $95.47-$99.85 |
52W Range | $79.52-$124 |
Market Cap | $24.1B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $2.8B |
Revenue Growth (YoY) | -23.7% |
Gross Profit (12 Mos) | $2.2B |
Diluted EPS | -$5.48 |
News
See moreYahoo Finance • 3 days ago
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
Yahoo Finance • 3 days ago
BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs
Yahoo Finance • 5 days ago
Report on COVID vaccine benefits being delayed at CDC: WaPo
About
CEO | Dr. Ugur Sahin M.D. |
CFO | Mr. Ramon Zapata-Gomez |
Address | An der Goldgrube 12, Mainz, Germany, 55131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7,807 |